This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Ru-shya Liu
Introduction
Ru-shya Liu is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of novel methods for generating monoclonal antibodies. Her work is characterized by a focus on creating stable fusion partners that enhance the efficiency of antibody production.
Latest Patents
Ru-shya Liu holds a patent for a "Stable rabbit-mouse fusion partner." This invention involves a stable xenogeneic fusion partner that results from the fusion of a mouse myeloma cell and a non-transformed rabbit partner cell. The fusion partner is notable for producing undetectable levels of antibodies, as determined by an enzyme-linked immunosorbent assay. The patent outlines a method for generating rabbit monoclonal antibodies, which includes fusing a non-transformed rabbit partner cell with a rodent myeloma cell to create a xenogeneic fusion partner. This innovative approach allows for the selection of a stable fusion partner that produces undetectable levels of antibodies, ultimately leading to the isolation of an antibody-producing cell line directed at a predetermined antigen.
Career Highlights
Ru-shya Liu is currently employed at Eli Lilly and Company, where she continues to advance her research in biotechnology. Her work has garnered attention for its potential applications in therapeutic development and diagnostics. Liu's innovative approach to antibody production is paving the way for new treatments and research methodologies.
Collaborations
Throughout her career, Ru-shya Liu has collaborated with esteemed colleagues, including Robert T. McCormack and Joseph Vincent Manetta. These collaborations have further enriched her research and contributed to the advancement of her projects.
Conclusion
Ru-shya Liu's contributions to the field of biotechnology, particularly through her patent on stable rabbit-mouse fusion partners, highlight her innovative spirit and dedication to advancing scientific knowledge. Her work at Eli Lilly and Company continues to impact the development of monoclonal antibodies, showcasing the importance of her research in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile